I certainly have mixed feelings about Pestel, having been a shareholder for 9 years. His connection with Penn Oncology makes me wonder if we have a partner brewing and this was one of the last holes to fill.

Rumors are this is one of 4 where high interest has been expressed. I am hopeful since we have no other alternative but to sell. Dr. J. has put together quite a team and they do not take lightly with whom they associate. I remain bullish.